# Tong Ren Tang Technologies > Chinese company **Wikidata**: [Q10917514](https://www.wikidata.org/wiki/Q10917514) **Source**: https://4ort.xyz/entity/tong-ren-tang-technologies ## Summary Tong Ren Tang Technologies is a Chinese public company founded in March 2000 as a subsidiary of the historic Tongrentang pharmaceutical group. It is listed on the Hong Kong Stock Exchange (stock code 1666) and operates in the technology and healthcare sectors, combining traditional Chinese medicine with modern scientific practices. The company serves as a key player in commercializing and innovating healthcare solutions rooted in centuries-old medical traditions. ## Key Facts - Founded in March 2000 as a subsidiary of Tongrentang, a renowned Chinese pharmaceutical company with over 350 years of history. - Listed on the Hong Kong Stock Exchange (HKEX) since July 9, 2010, under stock code 1666. - Headquartered in the People’s Republic of China, with a registered Unified Social Credit Identifier (USCI) of 91110000722600841J. - Operates under the legal name 北京同仁堂科技发展股份有限公司 (Beijing Tongrentang Technology Development Co., Ltd.). - Official website: http://www.tongrentangkj.com/ (content in Simplified Chinese). - Crunchbase organization identifier: tongrentang. - Classified as both a business and a public company, distinct from its parent entity Tongrentang. ## FAQs **What is Tong Ren Tang Technologies?** Tong Ren Tang Technologies is a Chinese public company established in 2000 as a subsidiary of the historic Tongrentang pharmaceutical group, focusing on integrating traditional Chinese medicine with modern technology. **When was Tong Ren Tang Technologies founded?** The company was founded in March 2000, though its parent organization, Tongrentang, has operated since 1669. **Where is Tong Ren Tang Technologies listed on the stock market?** It has been listed on the Hong Kong Stock Exchange (HKEX) under stock code 1666 since July 9, 2010. **Who owns Tong Ren Tang Technologies?** The company is owned by Tongrentang, a state-owned enterprise with a legacy in traditional Chinese medicine dating back to the Qing dynasty. ## Why It Matters Tong Ren Tang Technologies plays a critical role in modernizing traditional Chinese medicine (TCM) through technological innovation, ensuring its relevance in contemporary healthcare. As a publicly traded entity, it bridges centuries-old medical practices with global capital markets, fostering economic growth and cultural exchange. Its listing on the HKEX underscores its strategic importance in China’s efforts to internationalize TCM, while its affiliation with Tongrentang leverages the parent company’s historical credibility to advance scientific research and product development. ## Notable For - Being a subsidiary of Tongrentang, a brand synonymous with traditional Chinese medicine since 1669. - Successfully merging ancient medical practices with modern pharmaceutical technology. - Achieving a public listing on the Hong Kong Stock Exchange (HKEX: 1666) in 2010, enhancing its global market presence. - Holding a unique Unified Social Credit Identifier (91110000722600841J) registered in China. - Maintaining a Crunchbase profile (tongrentang) that highlights its role in the healthcare technology sector. ## Body ### History and Background Tong Ren Tang Technologies was established in March 2000 as a wholly owned subsidiary of Tongrentang, a state-owned pharmaceutical enterprise founded in 1669 during the Qing dynasty. The parent company is renowned for its traditional Chinese medicine (TCM) products, including herbal remedies and patented drugs. The creation of Tong Ren Tang Technologies marked a strategic shift toward modernizing TCM through technological innovation and commercial expansion. ### Corporate Structure and Ownership The company operates under the legal name 北京同仁堂科技发展股份有限公司 (Beijing Tongrentang Technology Development Co., Ltd.) and is wholly owned by Tongrentang. As a public company, it adheres to regulatory requirements for transparency and shareholder governance, distinct from its parent entity’s state-owned structure. ### Stock Exchange Listing On July 9, 2010, Tong Ren Tang Technologies debuted on the Hong Kong Stock Exchange (HKEX) under stock code 1666. This listing facilitated access to international capital, supporting its mission to globalize TCM products and technologies. The IPO underscored the company’s role in China’s broader initiative to integrate traditional practices with modern science. ### Operations and Focus Areas The company specializes in applying advanced technologies to TCM, including drug development, quality control systems, and digital healthcare solutions. Its work aligns with national strategies to promote TCM as a globally recognized medical system, emphasizing both cultural heritage and scientific validation. ### Digital and Legal Identifiers Tong Ren Tang Technologies maintains an official website (http://www.tongrentangkj.com/) with content in Simplified Chinese, serving as a primary platform for corporate and product information. The company is registered in China under the Unified Social Credit Identifier (USCI) 91110000722600841J, and its Crunchbase profile (tongrentang) highlights its contributions to the healthcare technology sector. ### Cultural and Economic Significance As a bridge between traditional medicine and modern industry, the company plays a dual role in preserving cultural heritage and driving economic growth. Its affiliation with Tongrentang grants it unparalleled access to historical medical knowledge, while its public listing enables collaboration with global stakeholders in pharmaceuticals and biotechnology. This unique position supports China’s efforts to expand the international influence of TCM, fostering both soft power and commercial opportunities. ## References 1. [企业概况](http://www.tongrentangkj.com/article_1352.html)